January/February 2023 Tech Guide: Immunoassay Analyzers
The January/February 2023 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
The January/February 2023 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Visby Medical has announced that its instrument-free RT-PCR COVID-19 test was granted EUA by the U.S.FDA for testing pooled patient samples.
In support of its pharmaceutical and clinical research clients, ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis.
FDA has reclassified antigen-based rapid influenza virus antigen detection systems intended to detect influenza virus directly from clinical specimens from Class I devices into Class II devices subject to special controls.
Read MoreThe company’s open, flexible, and scalable system is designed to empower clinical laboratorians to take complete control of their facilities.
Read MoreThe company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read MoreThe company’s Atellica Solution is expected to offer game-changing speed and flexibility for clinical chemistry and immunoassay testing.
Read MoreCurrently in development and not yet approved for sale, the system seeks to overcome existing sensitivity barriers in immunochemistry diagnostics.
Read MoreThe Cobas e 801 module is a dedicated, high-volume immunoassay system now available for countries accepting the CE mark.
Read MoreUltrasensitive assays enable researchers to detect proteins that are expressed at very low levels in response to drug treatment.
Read MoreKeeping pace with emerging biomarkers, and consolidating a broad test menu, are both important for developing and updating immunoassay instruments and kits.
Read MoreThe random access system offers a diversified immunoassay menu for allergy, autoimmunity, and biotherapy monitoring.
Read MoreThis month’s Product Spotlight features immunoassay analyzers from companies such as Dynex Technologies, bioMérieux, Tosoh Bioscience, and Inova Diagnostics.
Read MoreThe assay delivers cardiac troponin I results in about 15 minutes from either whole blood or plasma samples.
Read MoreA free upgrade procedure will be available for current customers, who will have access to numerous hardware and software advances and a comprehensive training program.
Read MoreRather than applying a full-well coating of antibody, the plate wells are precision spotted with small droplets of the same antibody arranged in an array format.
Read MoreOne company takes a novel approach to point-of-care diagnostics that reimagines the immunoassay method as serial reactions in connected microfluidic chambers.
Read MoreImmunoassay developers are staying current with new releases year round.
Read More